Monday's Biggest Analyst Calls: Nvidia, SpaceX, CoreWeave, Tesla & More
Wall Street analysts have been busy providing their insights and forecasts for various companies this Monday. Here are the most significant calls:
Nvidia Corporation (NVDA)
- Jefferies Group LLC downgraded Nvidia from a "buy" to a "hold" rating, citing concerns over the company's valuation and slowing growth.
- Morgan Stanley analyst Keith Weiss maintained an "overweight" rating and a $300 price target for Nvidia, arguing that the company's market share and technology leadership position make it a strong long-term investment.
SpaceX (SPACX)
- BofA Merrill Lynch analyst Mark Murphy maintained a "buy" rating and a $100 price target for SpaceX, citing the company's strong market position and growth potential.
- Morgan Stanley analyst Adam Jonas downgraded SpaceX from an "overweight" rating to a "neutral" rating, citing concerns over valuation and competition from established aerospace companies.
CoreWeave Inc (CWAVE)
- SunTrust Robinson Humphrey analyst William Stein maintained a "buy" rating and a $10 price target for CoreWeave, highlighting the company's strong product portfolio and growth potential in the AI-powered marketing automation space.
- Morgan Stanley analyst Michael Nallenberger downgraded CoreWeave from an "equal weight" rating to a "market perform" rating, citing concerns over valuation and competition from larger tech companies.
Tesla Inc (TSLA)
- JPMorgan Chase analyst Doug Short maintained a "neutral" rating and a $1,400 price target for Tesla, emphasizing the company's strong market position and growth potential, but also acknowledging challenges with production and delivery issues.
- Morgan Stanley analyst Adam Jonas maintained a "market perform" rating and a $450 price target for Tesla, citing concerns over valuation, production bottlenecks, and competition from traditional automakers.
Viking Global Investors LLC
- JPMorgan Chase analyst Stephen Tusa maintained a "neutral" rating and a $25 price target for Viking Global Investors, highlighting the private equity firm's strong track record and conservative investment approach.
- Morgan Stanley analyst Adam Jonas maintained a "market perform" rating and a $10 price target for Viking Global Investors, citing the firm's high valuation and lack of transparency.
Eli Lilly and Company (LLY)
- Goldman Sachs analyst David Tamber maintained a "buy" rating and a $185 price target for Eli Lilly and Company, highlighting the pharmaceutical company's strong product pipeline and potential for growth in the healthcare sector.
- Morgan Stanley analyst Adam Jonas maintained a "market perform" rating and a $135 price target for Eli Lilly and Company, citing concerns over competition and the impact of COVID-19 on the pharmaceutical industry.
<small>Source: CNBC — read the original story there.</small>